Nov 20 – Ryan Puplava gives this week's market wrap-up. Dave Keller at StockCharts.com provides his view on stocks and the macro-environment. Frank Holmes at US Global Investors discusses how millennials and Robinhood traders...

Nov 19 – Martin Armstrong warns that revolution is coming, not just to America but various parts of the globe as economies suffer under government lockdowns, political chaos, and civil unrest. Martin explains the steps on how this is likely to play out...

Nov 18 – Today, we speak with one of the first people to test Moderna's mRNA vaccine and how this is a breakthrough technology with much larger implications for cancer and other diseases, all of which are currently being worked on...

Nov 17 – The noted financial historian and strategist Russell Napier explains the big shift in how money is now being created and why he believes this will lead to higher rates of inflation for at least 10 years and perhaps even longer...

Nov 16 – In today's Lifetime Planning segment, Financial Sense Newshour's Jim Puplava speaks with real estate investor, CEO, and broker John Reeves of Reef Point Real Estate about the lowest interest rates in US history, the impacts they...

Nov 13 – Ryan Puplava gives this week's market wrap-up. Dan Wantrobski from Janney Montgomery Scott discusses the technical outlook for the market and the four major market disruptors. Ralph McLaughlin at Haus says the housing market...

Nov 12 – FS Insider speaks with Perch Perspectives' Jacob Shapiro about the latest Covid data, what is happening in Ethiopia right now next to one of the world's most important chokepoints for trade, as well as to get his thoughts on the elections...

Nov 11 – FS Insider speaks with ROBO Global's Senior Research Analyst Lisa Chai on the race for driverless technology and self-driving cars among auto manufacturers, tech companies, and various countries. Lisa discusses where driverless technology...

Nov 10 – FS Insider speaks with noted strategist and author Peter Zeihan about the recent vaccine announcement by Pfizer and why we shouldn't expect a swift rollout or distribution of this vaccine until a year from now. Peter also provides...